SLS NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Sellas Life Sciences Group Inc · Healthcare · Biotechnology

Open interactive chart View report data Download investor PDF
Latest close 11.32 USD
-14.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 71.8% above the Trend Line and sits at 68.5% of its 52-week range. The latest completed week returned -14.2%, after a -8.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 56/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 13d.

Setup score 63 out of 100
Latest Close 11.32 USD 24 Jul 2026
1W Return -14.2% latest completed week
4W Return -8.6% short-term follow-through
12W Return 129.6% quarterly tape
Trend Breadth 90.4% 47 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 32-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 3 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -14.2% Latest completed week; four-week move -8.6%. Indicator stack 95/73 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 56/100 conviction; expected move 17.4%. News sentiment 54/100 56 relevant articles in the latest sentiment read. Event risk 13d Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 71.8% above the Trend Line and sits at 68.5% of its 52-week range. The latest completed week returned -14.2%, after a -8.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9512-week average 0.81

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.95Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -8.6% over four weeks, 129.6% over 12 weeks, and 528.9% over one year. The current trend has remained active for 32 consecutive weeks.

Performance by holding period

1W-14.2%
4W-8.6%
12W129.6%
26W165.7%
52W528.9%
Active trend streak32 weeks
Active weeks in one year47
Trend breadth90.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.22Latest activity-pressure read.
Pressure change9.0%Four-week change in activity pressure.
Leadership136.42Latest relative-leadership reading.
RS change-32.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 64% Model confidence 61%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength38/100Blend of value, momentum, and quality. Underlying universe rank 63; rank 1 is best.
Value44/100Relative valuation strength. Underlying universe rank 57; rank 1 is best.
Quality43/100Profitability and accounting quality. Underlying universe rank 58; rank 1 is best.
Momentum45/100Medium-term price momentum. Underlying universe rank 56; rank 1 is best.
Growth45/100Revenue and earnings growth. Underlying universe rank 56; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-1.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-2152.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
-0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
4.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

SLS shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.54, expected move of 17.4%, and Sharemaestro trend signal active.

Conviction56/100
Expected move17.4%
Put/call volume0.54
Pressure37
Speculation41
Volatility96
Trend agreement85
Open options detail
Insider activity1 / 0

1 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 56 relevant articles.

17 positive · 28 neutral · 11 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings13dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
Options expected move17.4%Nearest-chain priced movement where available.
52-week drawdown-28.7%Distance below the 52-week high.
13-week volatility19.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+53.9%Week of 26 Jun.
Worst week-14.8%Week of 10 Jul.
Latest week-14.2%Week of 24 Jul.

Shape of recent returns

Strong gains11
Modest gains3
Flat weeks0
Modest losses3
Sharp losses9
Recent vol19.9%13-week weekly-return volatility.
Base vol15.5%52-week weekly-return volatility.
Up/down split29/22Count of positive and negative weeks in the 52-week window.
Average skew15.0% / -8.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape62/100

Trend, activity pressure, participation, and risk combine to a 62/100 tape read.

 Indicator analysis81/100

Latest 12-week confirmation: trend 12/12, activity pressure 10/12, relative leadership 12/12.

Activity pressure 0.95; 3 reversal markers Factors41/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 68; Small Cap Core rank 58 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options61/100

SLS shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.54, expected move of 17.4%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 17.4% Sentiment54/100

Weighted news tone is neutral across 56 relevant articles.

Sellas Life Sciences Group Inc (SLS) Institutional Confidence Insiders1 / 0

1 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings13d

Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202611.32 USD-14.2%6.59 USD2.37 USD1.22136.4230.0MOn
17 Jul 202613.19 USD3.4%6.31 USD2.30 USD1.51181.4038.4MOn
10 Jul 202612.76 USD-14.8%5.95 USD2.23 USD1.42173.2246.6MOn
3 Jul 202614.98 USD20.9%5.59 USD2.16 USD1.28241.0984.3MOn
26 Jun 202612.39 USD53.9%5.15 USD2.07 USD1.12200.5956.1MOn
19 Jun 20268.05 USD2.8%4.79 USD2.00 USD1.1095.5129.6MOn
12 Jun 20267.83 USD-4.9%4.57 USD1.96 USD1.25100.7629.9MOn
5 Jun 20268.23 USD-11.6%4.36 USD1.92 USD1.34121.9740.4MOn
29 May 20269.31 USD19.7%4.14 USD1.88 USD0.97147.5954.1MOn
22 May 20267.78 USD9.9%3.89 USD1.83 USD0.47120.6570.8MOn
15 May 20267.08 USD41.3%3.69 USD1.79 USD-0.01109.0568.3MOn
8 May 20265.01 USD1.6%3.53 USD1.76 USD-0.2951.6417.9MOn
1 May 20264.93 USD10.5%3.43 USD1.74 USD-0.2959.9619.8MOn
24 Apr 20264.46 USD-14.6%3.32 USD1.72 USD-0.2549.3027.8MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.